COL17A1 and hypereosinophilic syndrome: In case that symptomatic therapy is unsatisfactory, we strongly recommend testing anti-BP180 titers to help rule out BP and HES comorbidity in HES patients with recalcitrant blood eosinophilia or refractory lesions.